BSE Live
Oct 31, 16:01Prev. Close
437.85
Open Price
440.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:54Prev. Close
439.45
Open Price
440.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Venus Remedies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 315.40 | 297.36 | 352.11 | 371.67 | 399.37 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 315.40 | 297.36 | 352.11 | 371.67 | 399.37 | |
| Total Operating Revenues | 320.23 | 301.84 | 355.07 | 375.45 | 402.69 | |
| Other Income | 3.58 | 4.51 | 1.19 | 0.79 | 0.67 | |
| Total Revenue | 323.81 | 306.35 | 356.26 | 376.23 | 403.36 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 170.60 | 189.76 | 205.72 | 221.12 | 242.00 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 6.88 | 7.19 | 5.88 | 6.00 | 5.31 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 6.21 | -7.98 | -0.30 | 0.51 | -2.17 | |
| Employee Benefit Expenses | 33.79 | 30.26 | 27.82 | 25.02 | 25.02 | |
| Finance Costs | 13.05 | 25.15 | 35.44 | 33.56 | 36.74 | |
| Depreciation And Amortisation Expenses | 31.05 | 32.95 | 32.73 | 39.32 | 40.47 | |
| Other Expenses | 59.68 | 48.32 | 72.39 | 75.50 | 52.98 | |
| Total Expenses | 321.26 | 325.65 | 379.68 | 401.03 | 400.35 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2.55 | -19.30 | -23.42 | -24.80 | 3.01 | |
| Exceptional Items | -8.81 | -8.96 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -6.26 | -28.26 | -23.42 | -24.80 | 3.01 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 1.96 | -1.15 | 3.16 | -4.56 | 1.81 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 1.96 | -1.15 | 3.16 | -4.56 | 1.81 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -8.23 | -27.11 | -26.58 | -20.24 | 1.20 | |
| Profit/Loss From Continuing Operations | -8.23 | -27.11 | -26.58 | -20.24 | 1.20 | |
| Profit/Loss For The Period | -8.23 | -27.11 | -26.58 | -20.24 | 1.20 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -6.67 | -21.97 | -21.54 | -17.64 | 1.05 | |
| Diluted EPS (Rs.) | -6.67 | -21.97 | -21.54 | -17.64 | 1.05 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 72.61 | 83.85 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 148.51 | 158.14 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y